ATRS

Antares Pharma, Inc.
ATRS

Overview Fund Activity
Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

91 hedge funds and large institutions have $174M invested in Antares Pharma, Inc. in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 12 closing their positions.

Holders
91
Holders Change
+2
Holders Change %
+2.25%
% of All Funds
2.63%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
30
Reduced
26
Closed
12
Calls
$1.03M
Puts
$609K
Net Calls
+$425K
Net Calls Change
+$28K

Top Buyers

1
BC
1
Broadfin Capital
New York
$8.05M
2
JGC
2
J. Goldman & Co
New York
$3.41M
3
PI
3
Putnam Investments
Massachusetts
$3.75M
4
PWAM
4
Park West Asset Management
California
$1.75M
5
MIG
5
Mariner Investment Group
New York
$1.04M

Top Sellers

1
O
1
OrbiMed
New York
$11.2M
2
TAM
2
THB Asset Management
Connecticut
$0
3
HCM
3
Harvey Capital Management
Florida
$0
4
DM
4
Deerfield Management
New York
$33.2M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SC
101
Sumit Capital
New York
– -$47K -10,413 Closed
U
102
UBS
Switzerland
– -$25K -5,650 Closed
LTFS
103
Ladenburg Thalmann Financial Services
Florida
– -$2K -500 Closed
1 2 3 4
5